47
David Nutt FMedSci Professor of Neuropsychopharmacology Imperial College London [email protected] Visiting Professor at the Open University UK and Maastricht University NL Chair drugscience.org.uk [email protected] Future Drug Use and Drug Perspectives Denmark 2019

Future Drug Use and Drug Perspectives Denmark 2019...Safrole MDMA. PMMA. PMA and PMMA • Not typical stimulants • Slow onset of actions →overdose • Block monoamine oxidase inhibitor

  • Upload
    others

  • View
    2

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Future Drug Use and Drug Perspectives Denmark 2019...Safrole MDMA. PMMA. PMA and PMMA • Not typical stimulants • Slow onset of actions →overdose • Block monoamine oxidase inhibitor

David Nutt FMedSci

Professor of Neuropsychopharmacology Imperial College London

[email protected]

Visiting Professor at the Open University UK and Maastricht University NL

Chair – drugscience.org.uk

[email protected]

Future Drug Use and Drug

Perspectives

Denmark 2019

Page 2: Future Drug Use and Drug Perspectives Denmark 2019...Safrole MDMA. PMMA. PMA and PMMA • Not typical stimulants • Slow onset of actions →overdose • Block monoamine oxidase inhibitor

Oct 30th 2009

Sacked but not

gagged

Telling the truth about drugs is a risky business

Page 3: Future Drug Use and Drug Perspectives Denmark 2019...Safrole MDMA. PMMA. PMA and PMMA • Not typical stimulants • Slow onset of actions →overdose • Block monoamine oxidase inhibitor

The big killers are not controlled

0

10.000

20.000

30.000

40.000

50.000

60.000

70.000

80.000

90.000

Tobacco Alcohol Opiates

Nu

mb

er

of d

ea

ths

Personal communication based on pubic health sources from Professor D. Nutt, Psychiatrist and Edmund J. Safra Professor of Neuropsychopharmacology, Imperial

College London

ONS. 2015. Deaths related to drug poisoning in England and Wales: 2015 registrations. Available at:

https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths/bulletins/deathsrelatedtodrugpoisoninginenglandandwales/2015registrations#pa

racetamol-related-deaths-remain-stable-in-2015. Last accessed: February 2017.

0

200

400

600

800

1.000

1.200

1.400

1.600

1.800

2.000

Nu

mb

er

of d

ea

ths

Page 4: Future Drug Use and Drug Perspectives Denmark 2019...Safrole MDMA. PMMA. PMA and PMMA • Not typical stimulants • Slow onset of actions →overdose • Block monoamine oxidase inhibitor

Drugs ranked according to total harm

Nutt King & Phillips Lancet Nov 2010

Alcohol

Cannabis

Tobacco

Page 5: Future Drug Use and Drug Perspectives Denmark 2019...Safrole MDMA. PMMA. PMA and PMMA • Not typical stimulants • Slow onset of actions →overdose • Block monoamine oxidase inhibitor

No correlation of UK Drugs Act or the UN

Conventions with drug harms

5

0

1

2

3

4

5

0 20 40 60 80

UK

Dru

gs

Act

cla

ssif

icat

ion

ISCD results

A

C

B

U

linear r = 0.04

So the current UN Conventions and UK drugs laws

are not evidence-based – so immoral (and illegal)

What drives this dishonesty? Politics, the alcohol

industry, absolutist philosophies

That’s anther talk….

Page 6: Future Drug Use and Drug Perspectives Denmark 2019...Safrole MDMA. PMMA. PMA and PMMA • Not typical stimulants • Slow onset of actions →overdose • Block monoamine oxidase inhibitor

Prohibition leads to more harms

Many examples over the last century of how

prohibition has perverse consequences –

• Smoking opium → injecting heroin

• Ethanol prohibition → hooch and methanol

• Cannabis → skunk and synthetics (spice)

• Cocaine → crack

• MDMA → PMA/PMMA

• LSD/psilocybin → nBOMs etc.

• Heroin → synthetics AH7921 and fentanyls

Page 7: Future Drug Use and Drug Perspectives Denmark 2019...Safrole MDMA. PMMA. PMA and PMMA • Not typical stimulants • Slow onset of actions →overdose • Block monoamine oxidase inhibitor

As well as not reducing harm banning drugs severely impedes medical research

• Cannabis – pain, sleep, spasticity, cancer, PTSD

• Ecstasy (MDMA) – PTSD, Parkinson’s disease

• Psilocybin – depression, OCD, cluster headaches

• LSD – for terminal illnesses/ addiction

• Mephedrone & Naphyrone – for treatment of

depression and addiction

But current regulations make them

almost impossible to research

- So cant be resurrected from the

black hole of Schedule 1

Page 8: Future Drug Use and Drug Perspectives Denmark 2019...Safrole MDMA. PMMA. PMA and PMMA • Not typical stimulants • Slow onset of actions →overdose • Block monoamine oxidase inhibitor

How the 1971 UN Convention destroyed

research on psychedelics

Page 9: Future Drug Use and Drug Perspectives Denmark 2019...Safrole MDMA. PMMA. PMA and PMMA • Not typical stimulants • Slow onset of actions →overdose • Block monoamine oxidase inhibitor

1) Nutt, D.J, King, L.A. & Nichols, D.E. (2013) Effects of Schedule I drug laws on neuroscience research and treatment innovation, Nature Review Neuroscience, 14,

577- 585 Available at: http://www.nature.com/nrn/journal/v14/n8/abs/nrn3530.html (Accessed 31st Jan 2017)

2) Nutt, D. (2015) Illegal Drugs Laws: Clearing a 50-Year-Old Obstacle to Research, PLoS Biology, 13(1) Available at:

http://journals.plos.org/plosbiology/article/file?id=10.1371/journal.pbio.1002047&type=printable (Accessed 31st Jan 2017)

Nature REVIEWS NEUROSCIENCE

June 2013

Page 10: Future Drug Use and Drug Perspectives Denmark 2019...Safrole MDMA. PMMA. PMA and PMMA • Not typical stimulants • Slow onset of actions →overdose • Block monoamine oxidase inhibitor

Novel 5-HT2A psychedelics

designed to escape UN ban

1P-LSD

Probably as

safe as LSD

N-BOM SERIES

Much more toxic due to

blocki of serotonin reuptake

and other effects

Page 11: Future Drug Use and Drug Perspectives Denmark 2019...Safrole MDMA. PMMA. PMA and PMMA • Not typical stimulants • Slow onset of actions →overdose • Block monoamine oxidase inhibitor

D9-THC➢ Induces anxiety

➢ Psychotic-like

effects.

➢ Impairs memory

and learning

CBD

cannabidiol➢ Reduces anxiety

➢ Anti-psychotic

effects

➢ Improves memory

and learning

Have opposite effects on cannabinoid receptors in

the brain

Perverse effects of cannabis prohibition

Page 12: Future Drug Use and Drug Perspectives Denmark 2019...Safrole MDMA. PMMA. PMA and PMMA • Not typical stimulants • Slow onset of actions →overdose • Block monoamine oxidase inhibitor

Vanishing CBD

d9THC

Decrease in CBD due to

prohibition → stronger

THC products

“skunk” with greater

profit margins

Page 13: Future Drug Use and Drug Perspectives Denmark 2019...Safrole MDMA. PMMA. PMA and PMMA • Not typical stimulants • Slow onset of actions →overdose • Block monoamine oxidase inhibitor

Increased high THC/no CBD

cannabis strains

0

10

20

30

40

50

60

70

80

90

2002 2005 2008 2011

King et al 2005 Potter et al 2008 Hardwick/King Curran et al

2009

Police seizures Community sample

2008 – 80% skunk: CBD levels <0.1%; THC >15%.

2011 - 75% of samples skunk: CBD =0.01%

% S

am

ple

s

2018 - >95% skunk

Page 14: Future Drug Use and Drug Perspectives Denmark 2019...Safrole MDMA. PMMA. PMA and PMMA • Not typical stimulants • Slow onset of actions →overdose • Block monoamine oxidase inhibitor

High THC low

CBD

➔ more

psychotic

symptoms

0

1

2

3

4

5

6

7

8

Unusual

Experiences

Cognitive

Disorganisation

Introvertive

Anhedonia

Impulsive Non-

conformity

OL

IFE

Sco

re

No Cannabis

THC only

THC + CBD

Morgan & Curran, 2008 Brit J Psychiatry

**

*

We have known for a long time that cannabis

prohibition leads to greater harms

Page 15: Future Drug Use and Drug Perspectives Denmark 2019...Safrole MDMA. PMMA. PMA and PMMA • Not typical stimulants • Slow onset of actions →overdose • Block monoamine oxidase inhibitor

Skunk has different brain

effects from herbal

FMRI imaging -

Large perturbation of insula connectivity with skunk

Wall et al 2019 Journal of Psychopharmacology

Page 16: Future Drug Use and Drug Perspectives Denmark 2019...Safrole MDMA. PMMA. PMA and PMMA • Not typical stimulants • Slow onset of actions →overdose • Block monoamine oxidase inhibitor

3

4

5

6

7

8

Intoxicated Not intoxicated

Dela

yed

pro

se r

ecall

Low CBD:THC

High CBD:THC

group x day p=0.047

Morgan, Schafer, Freeman & Curran (2010) Brit J Psychiatry

*

And greater cognitive impairments

Memory –

prose

recall

Did this

make the UK

government

take stock

on policies?

NO!

Page 17: Future Drug Use and Drug Perspectives Denmark 2019...Safrole MDMA. PMMA. PMA and PMMA • Not typical stimulants • Slow onset of actions →overdose • Block monoamine oxidase inhibitor

In fact they made

it worse!

Testing prisoners for cannabis

➔ Synthetic cannabinoids =

Opening Pandora’s box

Because cannabis is illegal and users are prosecuted and prisoners are tested

➔ (logically) seek legal alternatives

Page 18: Future Drug Use and Drug Perspectives Denmark 2019...Safrole MDMA. PMMA. PMA and PMMA • Not typical stimulants • Slow onset of actions →overdose • Block monoamine oxidase inhibitor

And there are very many potential

synthetic cannabinoids…

RCS-4 AB-001 XLR-11 5F-PB-22 ADB-CHMINACA 5F-AMB

heteroaromatic

core

alkyl

substituent pendant

group

~2010 2015Some prisons estimate up to 90% of inmates now

using “spice” regularly despite their now being

illegal

And corrupting up to 5% of prison officers

Page 19: Future Drug Use and Drug Perspectives Denmark 2019...Safrole MDMA. PMMA. PMA and PMMA • Not typical stimulants • Slow onset of actions →overdose • Block monoamine oxidase inhibitor

Head shops used to sell “bubbles”

and “sparkle”

= weak stimulants e.g.

methiopropamine

Now all sales on black market

➔ synthetic cannabinoids

When spice hits the streets

Page 20: Future Drug Use and Drug Perspectives Denmark 2019...Safrole MDMA. PMMA. PMA and PMMA • Not typical stimulants • Slow onset of actions →overdose • Block monoamine oxidase inhibitor

Another example of prohibition failure

→rise of PMA/PMMA deaths in UK

0

10

20

30

40

50

60

1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012

Novel psychoactive substances

PMA

Nu

mb

er

of d

ea

ths

Number of drug-related deaths where selected substances were

mentioned on the death certificate, England and Wales

Page 21: Future Drug Use and Drug Perspectives Denmark 2019...Safrole MDMA. PMMA. PMA and PMMA • Not typical stimulants • Slow onset of actions →overdose • Block monoamine oxidase inhibitor

PMA is sold as “ecstasy” i.e. MDMA

PMAMDMA

Page 22: Future Drug Use and Drug Perspectives Denmark 2019...Safrole MDMA. PMMA. PMA and PMMA • Not typical stimulants • Slow onset of actions →overdose • Block monoamine oxidase inhibitor

Production of MDMA (ecstasy)

MDMASafrole

From sassafras oil

Page 23: Future Drug Use and Drug Perspectives Denmark 2019...Safrole MDMA. PMMA. PMA and PMMA • Not typical stimulants • Slow onset of actions →overdose • Block monoamine oxidase inhibitor

Alternative precursors → different products

Anethole PMA

PMMA

From aniseed oil

Seizure of massive quantity of safrole in Thailand in 2008 → reduction

in supply of MDMA

So underground chemists turn to other precursors such as aniseed oil

With disastrous consequences

Safrole MDMA

PMMA

Page 24: Future Drug Use and Drug Perspectives Denmark 2019...Safrole MDMA. PMMA. PMA and PMMA • Not typical stimulants • Slow onset of actions →overdose • Block monoamine oxidase inhibitor

PMA and PMMA

• Not typical stimulants

• Slow onset of actions → overdose

• Block monoamine oxidase inhibitor so can get serotonin

syndrome

→ hyperthermia, brain and muscle damage and

death

An example of how the “war on drugs” leads to collateral

deaths.

Page 25: Future Drug Use and Drug Perspectives Denmark 2019...Safrole MDMA. PMMA. PMA and PMMA • Not typical stimulants • Slow onset of actions →overdose • Block monoamine oxidase inhibitor

25

-1 0 1 2 3 4 5 6 7 8

Cannabis

Benzodiazepine analogues

Novel amphetamines

Mephedrone

MPA

Synthetic cathinones

Piperazines

Benzofurans

Amphetamine

MDMA

Cocaine/crack

Ketamine

PMA/PMMA

GHB/GBL

SCRAs

AMT

Heroin

Index of fatal toxicity Ln(Tf)

King and Corkery Journal of Psychopharmacology 2017

Comparative toxicity of drugs

Log scale

Page 26: Future Drug Use and Drug Perspectives Denmark 2019...Safrole MDMA. PMMA. PMA and PMMA • Not typical stimulants • Slow onset of actions →overdose • Block monoamine oxidase inhibitor

The remarkable impact of mephedrone

to reduce UK stimulant deaths

Page 27: Future Drug Use and Drug Perspectives Denmark 2019...Safrole MDMA. PMMA. PMA and PMMA • Not typical stimulants • Slow onset of actions →overdose • Block monoamine oxidase inhibitor

Police complicity: The Scunthorpe two (17/03/10)

Two young men found dead

“Officers believe both lads had M-CAT (mephedrone) and

also had access to heroin substitute methadone which they

used to bring them down from the high of mephedrone”

- they had also been drinking heavily until 2am

Nick's dad wept as he urged youngsters to avoid the drug…

"I don't want him to be labelled a druggie because he wasn't.

He was just on a night out with friends enjoying himself, a

normal, caring, hard-working lad.“” (The Sun, 17/03/10)

Media clamor to get the drug banned

Page 28: Future Drug Use and Drug Perspectives Denmark 2019...Safrole MDMA. PMMA. PMA and PMMA • Not typical stimulants • Slow onset of actions →overdose • Block monoamine oxidase inhibitor

It looks like amphetamine..

→ make it Class B like amphetamine

(could have been worse since they could have decreed

its effects were like MDMA = class A !)

.. and users describe effects somewhat like amphetamine

ACMD “Consideration of the cathinones” report March 2010

Page 29: Future Drug Use and Drug Perspectives Denmark 2019...Safrole MDMA. PMMA. PMA and PMMA • Not typical stimulants • Slow onset of actions →overdose • Block monoamine oxidase inhibitor

But the antismoking drug bupropion

(Zyban) also looks like amphetamine

For which there is no evidence of abuse, toxicity or harms

– so had to be exempted from the new law!

ACMD “Consideration of the cathinones” report March 2010

But all other cathinones now illegal

So pharmaceutical companies will

never be able to economically

develop newer more effective

versions of bupropion – research

field now dead

Page 30: Future Drug Use and Drug Perspectives Denmark 2019...Safrole MDMA. PMMA. PMA and PMMA • Not typical stimulants • Slow onset of actions →overdose • Block monoamine oxidase inhibitor

Monkey dust?

Page 31: Future Drug Use and Drug Perspectives Denmark 2019...Safrole MDMA. PMMA. PMA and PMMA • Not typical stimulants • Slow onset of actions →overdose • Block monoamine oxidase inhibitor

n-ethylpentylone

Maybe 10x more

potent than MDMA

Page 32: Future Drug Use and Drug Perspectives Denmark 2019...Safrole MDMA. PMMA. PMA and PMMA • Not typical stimulants • Slow onset of actions →overdose • Block monoamine oxidase inhibitor

Ketamine

• Tolerance & Dependence with repeated use

– + bladder damage/ functional brain changes

• Recreational use → Class B in UK

• → methoxetamine = safer alternative – probably

• → media hysteria → ban of all possible alternatives even

if much safer than ketamine

Page 33: Future Drug Use and Drug Perspectives Denmark 2019...Safrole MDMA. PMMA. PMA and PMMA • Not typical stimulants • Slow onset of actions →overdose • Block monoamine oxidase inhibitor

How the black market kills

Nov 2016 in Kent

Robert goes to score some

cannabis

Gets offered “ecstasy” as

well -- takes it

Dies as its fentanyl not

ecstasy

Which is why we need testing NOW

Page 34: Future Drug Use and Drug Perspectives Denmark 2019...Safrole MDMA. PMMA. PMA and PMMA • Not typical stimulants • Slow onset of actions →overdose • Block monoamine oxidase inhibitor

Acryloyl fentanyl • 23 analytically confirmed associated deaths reported

by Sweden between April and August 2016

W-18 • seizures of W-18 for example - counterfeit heroin

– linked to a recent spate of “heroin” overdoses across Australia

U-47700• In tablets in Scotland

• “Another powerful painkiller found in Prince's System:

U-47700 as well as fentanyl”

http://kstp.com/news/prince-u-47700-painkiller-

system-toxicology-drug-synthetic-opioid/4204272/

New synthetic opioids

Page 35: Future Drug Use and Drug Perspectives Denmark 2019...Safrole MDMA. PMMA. PMA and PMMA • Not typical stimulants • Slow onset of actions →overdose • Block monoamine oxidase inhibitor

• Number of fentanyl

exhibits

DEA National

Forensic Laboratory

Information System

• Peak in 2006 due to

supply from an illicit

lab in Mexico

Huge problem in USA and Canada

Page 36: Future Drug Use and Drug Perspectives Denmark 2019...Safrole MDMA. PMMA. PMA and PMMA • Not typical stimulants • Slow onset of actions →overdose • Block monoamine oxidase inhibitor

• injectable anaesthetic products

– occasional misuse by medical professionals or from

access to diverted product

• transdermal patches present greater risk

– large amount of material within patch (milligrams)

– discarded after use (72 hr) but significant residual

drug

– cut up and smoked/swallowed, or extracted for

injection

– unpredictable dosage, so risk of overdose and death

Pharmaceutical fentanyls

Page 37: Future Drug Use and Drug Perspectives Denmark 2019...Safrole MDMA. PMMA. PMA and PMMA • Not typical stimulants • Slow onset of actions →overdose • Block monoamine oxidase inhibitor

• Fentanyl

– 0.1mg iv equivalent to 10mg iv morphine i.e.(x100)

• Alfentanil

– potency ~0.3x fentanyl, very rapid onset, short action

• Remifentanil

– 2x fentanyl, rapid onset & recovery

• Sufentanil

– 5x fentanyl, most potent analogue used in humans

• Carfentanil

– 100x fentanyl, fast acting, limited to veterinary use

– explored by military as an ‘incapacitating agent’

• Lofentanil

– 120x fentanyl, long lasting, mainly used for research

Legitimate fentanyls

Page 38: Future Drug Use and Drug Perspectives Denmark 2019...Safrole MDMA. PMMA. PMA and PMMA • Not typical stimulants • Slow onset of actions →overdose • Block monoamine oxidase inhibitor

The worrying rise of fentanyls

38

0

10.000

20.000

30.000

40.000

50.000

60.000

70.000

80.000

90.000

Tobacco Alcohol Opiates

0

200

400

600

800

1.000

1.200

1.400

Fentanyl 75 of which

carfentanil 27

1 50x >1000x

Page 39: Future Drug Use and Drug Perspectives Denmark 2019...Safrole MDMA. PMMA. PMA and PMMA • Not typical stimulants • Slow onset of actions →overdose • Block monoamine oxidase inhibitor

• in stimulants

– in cocaine and ‘crystal meth’

– Connecticut June’16: ‘coke’ – 12 users, 3

deaths, 4 in intensive care

• in benzodiazepines

– fake ‘Xanax’ (Alprazolam + paracetamol)

• in e-cigarette liquids

– with synthetic cannabinoids

Fentanyls found in other illicit drugs

Page 40: Future Drug Use and Drug Perspectives Denmark 2019...Safrole MDMA. PMMA. PMA and PMMA • Not typical stimulants • Slow onset of actions →overdose • Block monoamine oxidase inhibitor

Much higher potency than heroin

–1 gram fentanyl ≈ 20 g diamorphine ≈ 50 g

‘street’ heroin

1 kg fentanyl from China costs ~$5,000

–equivalent to 50kg street heroin

distribution value (as 50kg ‘heroin’) ~ $5M

–short supply chain, few ‘middle men’, so

nearly all profit

• other fentanyl analogues even greater

potency

Big money to be made in fentanyls

Page 41: Future Drug Use and Drug Perspectives Denmark 2019...Safrole MDMA. PMMA. PMA and PMMA • Not typical stimulants • Slow onset of actions →overdose • Block monoamine oxidase inhibitor

Some ways forward

Page 42: Future Drug Use and Drug Perspectives Denmark 2019...Safrole MDMA. PMMA. PMA and PMMA • Not typical stimulants • Slow onset of actions →overdose • Block monoamine oxidase inhibitor

Restoring reason re cannabis

Dutch coffee shops → separate hard and soft drug market

→ medical cannabis also

US states. Israel, Canada, Uruguay, Germany, Spain

→ medical cannabis

some → legal recreational cannabis

Others lag behind on medical cannabis for fear of slippage into

recreational use despite having amongst highest percent

recreational users in the world

Page 43: Future Drug Use and Drug Perspectives Denmark 2019...Safrole MDMA. PMMA. PMA and PMMA • Not typical stimulants • Slow onset of actions →overdose • Block monoamine oxidase inhibitor

Drug testing

Page 44: Future Drug Use and Drug Perspectives Denmark 2019...Safrole MDMA. PMMA. PMA and PMMA • Not typical stimulants • Slow onset of actions →overdose • Block monoamine oxidase inhibitor

Regulated market gives best resultsDrugScience Policy MCDA results – cannabis

44Rogeberg et al 2018 International J of Drug Policy

Page 45: Future Drug Use and Drug Perspectives Denmark 2019...Safrole MDMA. PMMA. PMA and PMMA • Not typical stimulants • Slow onset of actions →overdose • Block monoamine oxidase inhibitor

Saving the world from drink?

Alcohol ➔ 3.5 million premature

deaths per year – many in young

people

Neuroscience can give us a safer

“synthetic” alcohol

New Scientist 2006

The Scientist Jan 2011

But would this now be legal in the

UK?

Do you want it Denmark?

Page 46: Future Drug Use and Drug Perspectives Denmark 2019...Safrole MDMA. PMMA. PMA and PMMA • Not typical stimulants • Slow onset of actions →overdose • Block monoamine oxidase inhibitor

Replace alcohol with nitrous oxide?

• Strong and fast pleasurable effect

• Rapid recovery, over in mins, so back in control

• → so lower risk of assault than when drunk for

hours

• Safer to drive home

• No hangover – less loss of work time

• Less toxic to the body

• Less addictive

Page 47: Future Drug Use and Drug Perspectives Denmark 2019...Safrole MDMA. PMMA. PMA and PMMA • Not typical stimulants • Slow onset of actions →overdose • Block monoamine oxidase inhibitor

Thanks and questions?

For the truth about drugs visit

www.DrugScience.org.uk

Or read my book …